VSEE HEALTH, INC.
Financial highlights
| Metric | FY December 31, 2025 | FY September 3, 2025 | FY December 31, 2024 | FY September 30, 2024 | FY June 30, 2024 |
|---|---|---|---|---|---|
| Revenue | $14.6M | — | $10.4M | — | — |
| Gross profit | $7.4M | — | $7.2M | — | — |
| Operating income | -$9.6M | — | -$62.2M | — | — |
| Operating expenses | $16.9M | — | $69.3M | — | — |
| Cost of revenue | $7.3M | — | $3.2M | — | — |
| Cash from operations | -$3.4M | — | -$5.8M | — | — |
| Capital expenditure | $29,928 | — | $55,267 | — | — |
| Free cash flow | -$3.5M | — | -$5.8M | — | — |
| Share repurchases | $44 | — | $5,150 | — | — |
| Impairments | $0 | — | $56.7M | — | — |
| Total assets | $22.4M | — | $20.0M | $22.3M | $78.6M |
| Total liabilities | $17.0M | — | $20.0M | $21.4M | $25.5M |
| Total debt | — | $304,288 | — | — | — |
Shares outstanding 48.6M · Free float 79.1%
Annual filing data through FY ended December 31, 2025; float as of June 27, 2026.